Amyloid-bodies in the evolution of malignancies
PLOS One · 09.07.2026 · 21 (7) · e0353464
DOI: 10.1371/journal.pone.0353464 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 09.07.2026. Verfasst von Alexander Michael Grunfeld und 4 weiteren Autor:innen. Beteiligte Einrichtung: Sheila and David Fuente Graduate Program in Cancer Biology, Miller School of Medicine, University of Miami, Miami, Florida, United States of America. Hauptthemen laut MEDLINE: Neoplasms, Amyloid. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIA NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Tumorigenesis depends on the capacity for cancer cells to survive in the presence of various environmental stressors. An emerging paradigm in the study of cancer cell stress responses is their regulation by membrane-less intracellular compartments known as biomolecular condensates. While there has been considerable progress in our understanding of biomolecular condensates in cancer in vitro , a paucity of evidence remains for their presence and function in settings which more closely reflect in vivo tumor physiology. In this study, we use human tissues and an in vivo orthotopic mouse model to study the role of the Amyloid-body, a stress-induced condensate, in tumorigenesis. We present methodology to visualize Amyloid-bodies in tumors by multiple immunohistochemical approaches in addition to a semi-automated analysis pipeline. Analysis of multiple tumor types reveals that Amyloid-bodies are detectable at all tumor grades and stages, to varying degrees, and negatively correlate with the cell proliferation marker Ki-67. Finally, in an orthotopic mouse model of breast cancer, we show that silencing long noncoding ribosomal intergenic spacer RNA (rIGSRNA) involved in Amyloid-body formation accelerates tumorigenesis in vivo . Together, these results suggest that Amyloid-body formation occurs in human cancers, further establishing the physiological relevance of biomolecular condensates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Sheila and David Fuente Graduate Program in Cancer Biology, Miller School of Medicine, University of Miami, Miami, Florida, United States of America.
- Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, Florida, United States of America.
- Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida, United States of America.
- Medical Scientist Training Program, University of Miami Miller School of Medicine, Miami, Florida, United States of America.
- Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, Florida, United States of America.
ORCID-Profile: Karelia Paz, Daniel Bilbao, Stephen Lee
Förderung
- NIGMS NIH HHS
- NIA NIH HHS
- NCI NIH HHS
- National Institute of General Medical Sciences
- National Cancer Institute
- National Institute on Aging
Zitieren
APA
Grunfeld, A. M., Bokros, M., Paz, K., Bilbao, D., & Lee, S. (2026). Amyloid-bodies in the evolution of malignancies. PLOS One, 21(7), e0353464. https://doi.org/10.1371/journal.pone.0353464
Vancouver
Grunfeld AM, Bokros M, Paz K, Bilbao D, Lee S. Amyloid-bodies in the evolution of malignancies. PLOS One. 2026;21(7):e0353464. doi:10.1371/journal.pone.0353464
BibTeX
@article{Grunfeld2026,
author = {Grunfeld, Alexander Michael and Bokros, Michael and Paz, Karelia and Bilbao, Daniel and Lee, Stephen},
title = {Amyloid-bodies in the evolution of malignancies},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {7},
pages = {e0353464},
doi = {10.1371/journal.pone.0353464}
}
EUVIMED